| Yes, businesses have the same flaw with a bit of better incentives. With a prize based approach, what you want is for researchers to make small targetted gambles early in their career, earn their prize profits from those gambles, and work their way up into bigger gambles. There's nothing crazy about this scheme, it's how businesses have formed for hundreds of years. If a company wants to buy equity in the prizes of an independent researcher, I see no issue with this. > then why would this model not be possible in a government office I see no issue with governmental workers, or those from a university medial research center, or any other persons who can achieve the results from receiving this prize. > someone needs to pay for all of the trials that don't work The researchers. They are the one taking the risk. They are the one who would get the rewards. Skin in the game. > With a public funding scheme, the benefit analysis could be based on public health interests. Yes, we should directly pay the organization, or persons, based on the value they generate from their own. The bigger the public health interest, the more they should be paid. Right now we give a tiny piece to these people, and thus harm our incentives. Fully fund the results. It's risk-free. |
Whatever you do, you can't get around the fact that the people with medical knowledge need to convince the people who have the money to invest in them before any research can take place. There is simply no way to get rid of the pitching to bureaucrats step here, not even in the most idealized societies - research just needs too many resources for any one individual to control.